Charles Robb
2020
In 2020, Charles Robb earned a total compensation of $2.9M as Chief Business Officer and Secretary at Corcept Therapeutics, a 12% increase compared to previous year.
Compensation breakdown
| Bonus | $321,236 |
|---|---|
| Option Awards | $2,118,822 |
| Salary | $474,380 |
| Total | $2,914,438 |
Robb received $2.1M in option awards, accounting for 73% of the total pay in 2020.
Robb also received $321.2K in bonus and $474.4K in salary.
Rankings
In 2020, Charles Robb's compensation ranked 3,974th out of 13,090 executives tracked by ExecPay. In other words, Robb earned more than 69.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,974 out of 13,090 | 70th |
Division Manufacturing | 1,592 out of 5,621 | 72nd |
Major group Chemicals And Allied Products | 603 out of 2,254 | 73rd |
Industry group Drugs | 521 out of 1,954 | 73rd |
Industry Pharmaceutical Preparations | 395 out of 1,459 | 73rd |
Source: SEC filing on April 22, 2021.
Robb's colleagues
We found four more compensation records of executives who worked with Charles Robb at Corcept Therapeutics in 2020.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019